Hyderabad: Youth Selling Tydol Drug Illegally Held By DCA

Hyderabad: Officials from the Drugs Control Administration (DCA) busted a drug racket in the Old City of Hyderabad in raids on Wednesday, May 8. Acting on credible information, DCA officials raided different areas in the Charminar area along with the police and held one resident who was selling Tydol 100 tablets illegally to youngsters.

DCA officers found that Arshad Khan, a resident Aman Nagar A, Yakutpura, was illegally selling Tydol 100 tablets (Tapentadol tablets 100 mg) at the Charminar Bus Stand parking area, New Shahalibanda Road. Officers seized 400 tablets of Tydol 100 tablets during the raid. The total worth of the stocks seized was Rs. 23,000, said V B Kamalasan Reddy, director general of DCA.

Tapentadol is a centrally acting opioid analgesic used for the management of moderate to severe pain for both acute (following injury, surgery, etc.) and chronic musculoskeletal pain. It works by acting on the opioid receptors in the brain and spinal cord, thereby altering the way the body perceives and responds to pain, stated Kamalasan Reddy. Due to its potential for abuse and addiction, Tapentadol has been classified as a Schedule H1 drug under the Drugs and Cosmetics Act.

Arshad Khan, who was selling the drug in the Charminar area, does not possess any drug licence and was illegally selling the habit-forming drug Tapentadol addicts, stated the DCA in a release.

Schedule H1 drugs are those that have a high potential for abuse or indiscriminate use and are subject to stricter regulations regarding their sale, said Kamalasan Reddy. The inclusion of ‘Tapentadol’ in Schedule H1 means that it can only be sold by retail pharmacies with a prescription from a registered medical practitioner, he added.

T. Rajamouli, Assistant Director, Hyderabad zone, B. Lakshmi, Drugs Inspector, Charminar and S. Naveen, sub-inspector of police, Hussaini Alam police station were among the officers who carried out the raid. Further investigation will be carried out, and action will be taken as per the law against all the offenders, stated the DCA.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?